WAVE Life Sciences Ltd Stock
Price
Target price
€6.75
€6.75
-1.460%
-0.1
-1.460%
€18.64
07.11.25 / Stuttgart Stock Exchange
WKN: A1436W / Symbol: WVE / Name: WAVE Life / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
WAVE Life Sciences Ltd Stock
A loss of -1.460% shows a downward development for WAVE Life Sciences Ltd.
We see a rather positive sentiment for WAVE Life Sciences Ltd with 15 Buy predictions and 1 Sell predictions.
Based on the current price of 6.75 € the target price of 18 € shows a potential of 166.67% for WAVE Life Sciences Ltd which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for WAVE Life Sciences Ltd stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | -1.460% | -4.255% | 11.570% | -50.368% | -44.672% | 56.142% | 11.570% |
| Intellia Therapeutics Inc | -24.330% | -25.946% | -53.162% | -44.534% | -27.673% | -83.038% | -65.258% |
| Chromadex Corp | -1.750% | -13.178% | -8.197% | -9.677% | 8.738% | 198.348% | 52.174% |
| Polynovo Ltd | -3.620% | -7.639% | -14.744% | -45.041% | -45.041% | -48.047% | -59.697% |
Comments
WAVE Life Sciences (NASDAQ:WVE) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $18.00 price target on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Show more
Ratings data for WVE provided by MarketBeat
